BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36096431)

  • 1. Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals.
    Stokes W; Venner AA; Buss E; Tipples G; Berenger BM
    Clin Microbiol Infect; 2023 Feb; 29(2):247-252. PubMed ID: 36096431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbott ID NOW™ COVID-19 assay: do not discard the swab.
    MacDonald C; Desruisseaux C; Eckbo E; Li L; Locher K; Wong T; Grant J; Lavergne V; Schaeffer DF; Hoang LMN; Charles M
    Diagn Microbiol Infect Dis; 2023 Apr; 105(4):115832. PubMed ID: 36731196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.
    Cradic K; Lockhart M; Ozbolt P; Fatica L; Landon L; Lieber M; Yang D; Swickard J; Wongchaowart N; Fuhrman S; Antonara S
    Am J Clin Pathol; 2020 Jul; 154(2):201-207. PubMed ID: 32462195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™.
    Burnes LE; Clark ST; Sheldrake E; Faheem A; Poon BP; Christie-Holmes N; Finlay L; Kandel C; Phan M; Frankland C; Lau T; Gubbay JB; Corbeil A; Katz K; Kozak RA
    J Clin Virol; 2021 Aug; 141():104896. PubMed ID: 34174710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing.
    Chiu RYT; Kojima N; Mosley GL; Cheng KK; Pereira DY; Brobeck M; Chan TL; Zee JS; Kittur H; Chung CYT; Tsang E; Maran K; Yung RW; Leung AC; Siu RH; Ng JP; Choi TH; Fung MW; Chan WS; Lam HY; Lee KH; Parkin S; Chao FC; Ho SK; Marshak DR; Ma ES; Klausner JD
    Microbiol Spectr; 2021 Sep; 9(1):e0034221. PubMed ID: 34346748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.
    Lévesque S; Beauchemin S; Vallée M; Longtin J; Jacob-Wagner M; Dumaresq J; Dulcey C; Labbé AC
    J Med Virol; 2022 Sep; 94(9):4522-4527. PubMed ID: 35535382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples.
    Schroeder LF; Bachman MA; Idoni A; Gegenheimer-Holmes J; Kronick SL; Valdez R; Lephart PR
    J Appl Lab Med; 2022 May; 7(3):661-673. PubMed ID: 34755849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One Swab Fits All: Performance of a Rapid, Antigen-Based SARS-CoV-2 Test Using a Nasal Swab, Nasopharyngeal Swab for Nasal Collection, and RT-PCR Confirmation from Residual Extraction Buffer.
    Stokes W; Berenger BM; Scott B; Szelewicki J; Singh T; Portnoy D; Turnbull L; Pabbaraju K; Shokoples S; Wong AA; Gill K; Hu J; Tipples G
    J Appl Lab Med; 2022 Jun; 7(4):834-841. PubMed ID: 35258088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19.
    Stokes W; Berenger BM; Portnoy D; Scott B; Szelewicki J; Singh T; Venner AA; Turnbull L; Pabbaraju K; Shokoples S; Wong AA; Gill K; Guttridge T; Proctor D; Hu J; Tipples G
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1721-1726. PubMed ID: 33742322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the ID NOW among symptomatic individuals during the Omicron wave.
    Stokes W; Venner AA; Buss E; Tipples G; Berenger BM
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36848403
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Detection of SARS-CoV-2 From Throat Swabs Performed With or Without Specimen Collection From the Tonsils: Protocol for a Multicenter Randomized Controlled Trial.
    Hartvigsen B; Jakobsen KK; Benfield T; Gredal NT; Ersbøll AK; Grønlund MW; Bundgaard H; Andersen MP; Steenhard N; von Buchwald C; Todsen T
    JMIR Res Protoc; 2024 Jun; 13():e47446. PubMed ID: 38865190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department.
    NguyenVan JC; Gerlier C; Pilmis B; Mizrahi A; Péan de Ponfilly G; Khaterchi A; Enouf V; Ganansia O; Le Monnier A
    J Clin Virol; 2021 Dec; 145():105021. PubMed ID: 34768231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding saliva testing to oropharyngeal and deep nasal swab testing increases PCR detection of SARS-CoV-2 in primary care and children.
    Oliver J; Tosif S; Lee LY; Costa AM; Bartel C; Last K; Clifford V; Daley A; Allard N; Orr C; Nind A; Alexander K; Meagher N; Sait M; Ballard SA; Williams E; Bond K; Williamson DA; Crawford NW; Gibney KB
    Med J Aust; 2021 Sep; 215(6):273-278. PubMed ID: 34287935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical performance of the Abbott ID NOW 2.0 assay for SARS-CoV-2 detection in clinical samples from symptomatic patients.
    Han E; Lee S; Kim HS; Yu H; Lee GD; Kim Y; Kim M
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116164. PubMed ID: 38157639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled nasopharyngeal swab collection in a single vial for the diagnosis of SARS CoV-2 infection: An effective cost saving method.
    Agarwal R; Gupta E; Dubey S; Padhi A; Khodare A; Kumar G; Sarin SK
    Indian J Med Microbiol; 2021 Apr; 39(2):231-234. PubMed ID: 33515633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of oral swab specimen for SARS-CoV-2 detection with rapid point-of-care lateral flow antigen test.
    Mane A; Jain S; Jain A; Pereira M; Sirsat A; Pathak G; Bhoi V; Bhavsar S; Panda S
    Sci Rep; 2022 May; 12(1):7355. PubMed ID: 35513547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2.
    Berenger BM; Fonseca K; Schneider AR; Hu J; Zelyas N
    Diagn Microbiol Infect Dis; 2022 Apr; 102(4):115618. PubMed ID: 35007959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.